These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Mean platelet volume (MPV): new diagnostic indices for co-morbidity of tuberculosis and diabetes mellitus. Xu F; Qu S; Wang L; Qin Y BMC Infect Dis; 2021 May; 21(1):461. PubMed ID: 34016046 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity. Fernández RDV; Díaz A; Bongiovanni B; Gallucci G; Bértola D; Gardeñez W; Lioi S; Bertolin Y; Galliano R; Bay ML; Bottasso O; D'Attilio L Front Endocrinol (Lausanne); 2020; 11():126. PubMed ID: 32265833 [TBL] [Abstract][Full Text] [Related]
12. Serum levels of chemokines IP-10, IL-8 and SDF-1 serve as good biomarkers for diabetes-tuberculosis nexus. Aravindhan V; Kevinkumar V; Dhamodharan U; Viswanathan V J Diabetes Complications; 2018 Sep; 32(9):857-862. PubMed ID: 30025786 [TBL] [Abstract][Full Text] [Related]
14. Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon. Mascia C; Vita S; Zuccalà P; Marocco R; Tieghi T; Savinelli S; Rossi R; Iannetta M; Pozzetto I; Furlan C; Mengoni F; Mastroianni CM; Vullo V; Lichtner M PLoS One; 2017; 12(6):e0179400. PubMed ID: 28636655 [TBL] [Abstract][Full Text] [Related]
15. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment. Degner NR; Wang JY; Golub JE; Karakousis PC Clin Infect Dis; 2018 Jan; 66(2):198-205. PubMed ID: 29325084 [TBL] [Abstract][Full Text] [Related]
16. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses. Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590 [TBL] [Abstract][Full Text] [Related]
17. Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity. Kumar NP; Banurekha VV; Nair D; Dolla C; Kumaran P; Babu S Tuberculosis (Edinb); 2018 Jan; 108():127-135. PubMed ID: 29523313 [TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines. Kumar NP; Banurekha VV; Nair D; Kumaran P; Dolla CK; Babu S Tuberculosis (Edinb); 2015 Dec; 95(6):707-712. PubMed ID: 26354610 [TBL] [Abstract][Full Text] [Related]
19. Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyl arginine, and insulin resistance in type 2 diabetic patients. Toupchian O; Sotoudeh G; Mansoori A; Nasli-Esfahani E; Djalali M; Keshavarz SA; Koohdani F J Clin Lipidol; 2016; 10(4):798-807. PubMed ID: 27578110 [TBL] [Abstract][Full Text] [Related]
20. Non-classical circulating monocytes in severe obesity and obesity with uncontrolled diabetes: A comparison with tuberculosis and healthy individuals. Resende DP; da Costa AC; de Souza Rosa LP; Rodrigues AP; Santos ASEA; Cardoso CK; Sousa JD; Kipnis A; Silveira EA; Junqueira-Kipnis AP Tuberculosis (Edinb); 2019 Jan; 114():30-41. PubMed ID: 30711155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]